Shares of TherapeuticsMD Inc. TXMD, +1.83% advanced 1.83% to $4.45 Friday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average DJIA, +0.10% rising 0.10% to 34,429.88 and the NASDAQ Composite Index COMP, -0.18% falling 0.18% to 11,461.50. The stock’s rise snapped a two-day losing streak. TherapeuticsMD Inc. closed $26.05 short of its 52-week high ($30.50), which the company achieved on January 4th.
The stock outperformed some of its competitors Friday, as AbbVie Inc. ABBV, +1.26% rose 1.26% to $163.66, Pfizer Inc. PFE, -0.33% fell 0.33% to $50.91, and Agile Therapeutics Inc. AGRX, +1.30% rose 1.30% to $0.20. Trading volume (26,752) remained 30,574 below its 50-day average volume of 57,326.